Excellent outcome after repeated changes of tyrosine kinase inhibitor therapy for chronic myeloid leukaemia in complete cytogenetic response due to minor side effects

Pratap Neelakantan, Katayoun Rezvani, Philippa May, Gareth Gerrard, Bua Marco, Christos Paliompeis, Alistair Reid, John Goldman, David Marin, Dragana Milojkovic, Pratap Neelakantan, Katayoun Rezvani, Philippa May, Gareth Gerrard, Bua Marco, Christos Paliompeis, Alistair Reid, John Goldman, David Marin, Dragana Milojkovic

No abstract available

Keywords: chronic myeloid leukaemia; imatinib; side-effect; therapy change; tyrosine kinases.